Serotonin-binding protein (SBP) is a soluble protein found in synaptic vesicles of central and peripheral serotonergic neurons. Experiments were undertaken to determine whether serotonin (5 HT) is physiologically stored as a complex with SBP in uiuo.
1979), and in the neural layers of the gastrointestinal tract (Jonakait et al., 1977 (Jonakait et al., , 1979 . Lesions of the raphe nuclei deplete SBP in the forebrain (Tamir and Kuhar, 1975) ; transection of the spinal cord depletes SBP distal to the lesion while causing a proximal accumulation of the protein (Tamir and Gershon, 1979) ; 5,7-dihydroxytryptamine treatment depletes SBP from the small intestine (Jonakait et al., 1977) . The protein, moreover, appears to be neurectoderm specific. It is encountered in serotonergic neurons and in the neural crest-derived parafollicular cells of the thyroid gland, which store 5-HT (Bernd et al., 1981) ; however, SBP cannot be detected in 5-HT-storing enteroendocrine cells (Gold et al., 1982) , which are of entodermal origin, or in mast cells or platelets, which are derived embryologically from mesoderm (Huang et al., 1982; Tamir et al., 1980 Tamir et al., ,1981 Tamir et al., ,1982a ). Gershon et al. Vol. 3, No. 10, Oct. 1983 SBP is probably a component of 5HT storage vesicles. Evidence that favors this conclusion includes the following observations. (i) SBP accumulates above a spinal cord lesion at a rate consistent with fast axonal transport (Tamir and Gershon, 1979) . Fast transport is associated with membrane-enclosed or membranous components destined for the synaptic apparatus (Grafstein, 1977) .
(ii) SBP is enriched 4-fold over the synaptosomal supernatant in a vesicular fraction derived from synaptosomes (Tamir and Gershon, 1979) . (iii) SBP is released in a Ca*+-dependent manner, along with 5-HT, by electrical stimulation of enteric neurons, whereas the cytosol marker, lactic acid dehydrogenase, is not (Jonakait et al., 1979) . This protein release implies that exocytosis is the SBP release mechanism and that, in turn, implies an intravesicular localization of the stored SBP.
Our working hypothesis is that SBP functions as a storage protein within serotonergic vesicles. The binding of the amine to the protein may reduce osmotic pressure within the vesicles. It has been estimated from studies of enteric serotonergic neurons in organotypic tissue cultures that the intracellular concentration of 5-HT is quite high, about 7 mM (Liu et al., 1982) . The intravesicular concentration is likely to be higher still. Thus there must be some mechanism to prevent osmotic swelling of vesicles. This could be accomplished if one molecule of SBP bound several molecules of 5HT. Properties of SBP that have been established indicate that the molecule is remarkably well suited to a role as a storage protein. The binding of 5-HT by SBP is extremely tight under intracellular conditions. In K+-and Fe*+-containing buffers a dissociation constant has been measured in the range of 10-l' M (Jonakait et al., 1977; Gershon and Tamir, 1981a) . In the presence of Na+ or Ca'+, however, SBP loses its affinity for 5-HT (Tamir et al., 1976; Gershon and Tamir, 1981a) . It is therefore likely that very little free 5-HT will be in equilibrium with intracellular SBP until the protein is saturated. On the other hand, exposure of SBP to extracellular fluid at the time of exocytosis would cause 5-HT to dissociate from the protein so as to be free to diffuse to its receptors.
The current study was undertaken in order to test the hypothesis that 5-HT is bound to SBP in serotonergic neurons in vivo. We have sought to determine whether newly taken up [3H]5-HT can be recovered from central and peripheral neurons as a complex with SBP. In addition, we have analyzed the effect of lowering the concentration of endogenous 5-HT on the capacity of SBP to bind exogenous [3H]5-HT in vivo. 5-HT was depleted for this purpose by putting animals on a tryptophan-free diet to avoid the use of drugs such as reserpine and indole neurotoxins that may deplete 5-HT, in part, through an action on SBP.
Materials and Methods
Intraventrical perfusion of pH]5-HT Rats, pretreated with clorgyline, (25 mg/kg, i.p.; 30 min) were anesthetized lightly with ether and mounted in a small animal stereotaxic apparatus (Kopf No. 900). A midline incision was made in the scalp and burr holes, 1 mm diameter, were made in the skull, 2 mm to the left and right of the midline on bregma. Perfusion of [3H]5-HT was done through a 25 gauge needle that was stereotaxically inserted into a lateral ventricle through the burr hole(s) to an average depth of 4 to 6 mm from the cortical surface. The perfusion (using a Sage pump, No. B41A) was carried on for 2.5 to 3.0 hr, using [3H]5-HT (12 Ci/mmol; 10e4 M; 0.5 ml). Half the volume was given into the left lateral ventricle (for the first 1.5 hr) and the remaining volume was given into the right lateral ventricle. The rats were kept under light ether anesthesia throughout the perfusion and the animals were constatly monitored to determine whether there was any efflux (backflow) from the cannula. At the end of the perfusion period the animal was decapitated and the brain (without cerebellum) was immediately removed and processed as described below.
Isolation of brain SBP.PHlS-HT complex. The perfused rat brain was rinsed with 0.32 M sucrose in 1 mM potassium phosphate buffer, pH 7.5, and homogenized in 5.0 ml of the same buffer. The homogenate was centrifuged at 100,000 X g for 20 min. A sample was removed, acidified, and stored frozen until assays of its concentration of E3H]5-HT and 5-[3H]hydroxyindolacetic acid ([3H]5-HIAA) could be performed. The [3H]5-HT that bound to protein in vivo was separated from free [3H]5-HT by passing 0.5 ml of the 100,000 X g supernatant through a column of Sephadex G-50 (1 x 10 cm). An aliquot of the separated [3H]5-HT.SBP complex was subjected to SDS-lo% PAGE as previously described (Tamir et al., 1980; Tamir, 1982) . To control for the possibility that the 13H]5-HT.SBP complex actually formed during the homogenization of the brain and subsequent steps of centrifugation and not in vivo, we added [3H]5-HT, at the concentration found in the brains of perfused rats at the time of decapitation, to a nonperfused brain just before homogenization. The homogenization, centrifugation, and Sephadex column chromatography were then carried out identically as for perfused brains. Less than 10% of the counts found to be bound to protein isolated from animals perfused with [3H]5-HT in vivo were found to be bound to protein when the [3H] 5-HT was added just prior to homogenization. The [3H] 5-HT. SBP complex was also prepared from protein extracted from unlabeled tissue for comparison with the material formed in vivo by incubating partially purified SBP (from which endogenous 5-HT had been removed by extensive dialysis) with [3H]5-HT (0.2 pM, 10 Ci/ mmol New England Nuclear;) and Fe*+ and separating the free 5-HT from the bound form on Sephadex G-50, as previously described (Tamir et al., 1976; Tamir, 1982) .
Isolation of the enteric SBP. PHJSHT complex. The longitudinal muscle with adherent myenteric plexus (LM-MP) was removed from the entire small intestine of one rabbit and incubated (1 hr; 37°C) in Krebs solution (20 ml) with [3H]5-HT (0.5 pM) in the presence of the monoamine oxidase (MAO) inhibitors, clorgyline (10 pM) and pargyline (0.1 mM), as well as the norepinephrine uptake inhibitor, desmethylimipramine (10 nM). Following incubation, the tissue was rinsed and removed to 5 ml of sucrose (0.32 M) buffered with potassium phosphate buffer (1 mM, pH 7.5) to which the following proteolytic enzyme inhibitors were added: phenylmethylsulfonyl flu- The tissue was vigorously homogenized (Polytron, Brinkmann Instruments; 45 set) and the homogenate was immediately centrifuged (100,000 x g, 30 min). An aliquot (0.5 ml) of the supernatant was applied to a Sephadex G-50 column and the [3H]5-HT. SBP complex was separated from free [3H]5-HT as described above.
The complex of SBP.
[3H]5-HT was formed with protein extracted from the tissue in the following way. The LM-MP from rabbit small intestine was homogenized in 5 ml of sucrose (0.32 M) containing potassium phosphate buffer (1 mM, pH 7.5) and PMSF (2 mM) using a Polytron (45 set). The homogenate was centrifuged (100,000 X g, 60 min) and the supernatant was fractionated with (NH&S04. The fraction that precipitated between 0 and 30% saturation was centrifuged (15,000 x g, 15 min). The pellet was dissolved in potassium phosphate buffer (0.02 M, pH 7.5) and dialyzed against the same buffer, to which 10% glycerol had been added, for 18 hr. The dialyzed protein was used to prepare the complex as described previously (Tamir, 1982) . Briefly, SBP (125 pg) was incubated with Fe2+ (0.1 mM) and [3H]5-HT (2 X 10e7 M) and the protein-bound [3H]5-HT was separated from free [3H]5-HT by molecular sieve chromatography on Sephadex G-50.
SDS electrophoresis
Electrophoresis on 10% polyacrylamide tube gels was carried out using the SDS buffer system of Laemmli (1970) . For electrophoretic analysis, the protein or protein . Fe2+.
[3H]5-HT complex was dissolved in a buffer containing 0.5 M Tris-HCl (pH 6.8), 0.05% SDS, 0.012% mercaptoethanol, 10% glycerol, and 2 mM EDTA. Following electrophoresis, the gels were either stained with Coomassie blue and destained as described by Fairbanks et al. (1971) , or, to detect radioactivity, the gels were sliced (l-mm sections), placed in scintillation vials, and dissolved in tissue solubilizer TS-1 (0.4 ml, 55°C overnight; Research Products, Elkgrove, IL). After cooling, the sections were counted in a toluene-based scintillation fluid (10 ml).
Molecular weight estimation
Estimates of molecular weight were made by SDS gel electrophoresis including the following standards: bovine serum albumin, 68 kd; tubulin, 55 to 57 kd, catalase, 60 kd; and ovalbumin, 43 kd. The sources of these proteins were: bovine serum albumin and catalase, Calbiochem, La Jolla, CA; and ovalbumin, Pentex-Niles, Kankakee, IL; tubulin was a generous gift of Dr. D. Soifer. It is recognized that estimates of molecular weight based on SDS gel electrophoresis may be in error because SDS binding depends on the nature of the protein. Since no second method was used to verify the estimated molecular weight, we have referred to them as apparent molecular weights.
Treatment of rats with p-chlorophenylalanine
Rats (male, Sprague-Dawley, 300 gm) were injected with parachlorophenylalanine methyl ester (PCPA; 200 mg/kg, i.p., on 2 consecutive days). On the third day the rats were treated with clorgyline and perfused with [3H] 5-HT as described above.
Tryptophan-free diet. Rats (300 gm) were placed in individual cages. Control animals (5) received normal Purina Laboratory Chow (5001) and experimental animals (5) received a tryptophan-free diet prepared by Nutritional Biochemicals (Cleveland, OH). Food and water were consumed ad libidum. Light-dark cycles of 12 hr were maintained identically for both groups. At indicated intervals a paired control and an experimental animal were treated with clorgyline and perfused through the lateral ventricles with [3H]5-HT for the estimation of the in uiuo formation of the [3H]5-HT.SBP complex as described above.
Light microscopic radioautography
Segments of ileum were removed from adult rabbits. The segments were equilibrated for 15 min in Krebs solution and then incubated for 30 min with [3H]5-HT (0.5 PM). Tissues were fixed for 2.5 hr in a hypertonic solution (Fischman and Gershon, 1964) of 2.0% glutaraldehyde, 2% formaldehyde (from paraformaldehyde), 0.5% acrolein, 0.5% dimethylsulfoxide, 3% sucrose, and 2 mM CaC12 in 0.1 M sodium cacodylate buffer and, after a wash in buffer of not more than 5 min, postfixed for 1 hr in 1% OsOI (identically buffered). They were then rapidly dehydrated with ethanol, cleared in propylene oxide, and embedded in Epon 812. Alternatively, some material was embedded in paraffin. For this procedure postfixation in 0~0~ was omitted. Rat brains that had been perfused with [3H]5-HT were treated identically except that tissues were fixed by transcardiac perfusion, first with 100 ml of saline containing heparin and then with 500 ml of fixative. After 20 min, the fixed brains were removed and placed in fixative for an additional 2 hr prior to dehydration and embedding in paraffin.
For light microscopy, Epon sections, 1 pm in thickness, or paraffin sections, 8 pm in thickness, were cut and mounted on glass slides that had been precoated with gelatin containing 0.5 gm/liter of chromium alum. The slides were then dipped in Ilford L4 emulsion (diluted 1:l with water), dried, and exposed for 7 days under an atmosphere of 100% C02. Slides were developed for 5 min in Kodak D-19 developer, and after completion of photographic processing, Epon sections were stained with toluidine blue and paraffin sections were stained with cresyl violet. Slides were examined both by brightfield and darkfield microscopy.
Electron microscopic (EM) radioautography
Intestinal tissue that had been incubated with [3H]5-HT for analysis of the formation of the [3H]5-HT.SBP complex was also subjected to EM radioautography in order to determine possible sites of SBP localization. Incubated tissue was washed for 10 min in iced Krebs solution before fixation and after incubation in order to permit nonbound [3H]5-HT and radioactive metabolites to wash out of the tissue (Gershon and Ross, 1966a, b) . Segments of LM-MP were then pinned flat and fixed for 2 hr at room temperature in the same triple aldehyde solution used for light microscopic radioautography. Following extensive washing in buffer, the tissue was post-1904 Gershon et al. Vol. 3, No. 10, Oct. 1983 fixed in iced 3% KMn04 in Krebs-Ringer phosphate buffer (CaCl* replaced by MgC12; Hokfelt, 1968) for 40 min. Tissues were stained en bloc with 0.1 gm of magnesium uranyl acetate in 20 ml of physiological saline, dehydrated in ethanol, and embedded in Spurr's low viscosity epoxy resin. Silver sections were placed on collodion-coated glass slides (Kopriwa, 1975) . Some sections were stained with uranyl acetate and lead citrate, whereas others were not stained until after they had been picked up on grids. Sections were processed on this flat substrate with Ilford L4 photographic emulsion for EM radioautography as described previously (Gershon and Sherman, 1982) . The combined aldehyde-permanganate procedure permits simultaneous visualization of [3H]5-HT (by radioautography) and noradrenergic varicosities (50-nm dense cored vesicles) in tissue (Gershon and Sherman, 1982) .
Separation and assay of fH]S-HT and its metabolite.
The high speed supernatant obtained from either brain or gut whole homogenate was passed through a column of Sephadex G-10 (Boireau et al., 1976; Gershon and Tamir, 1981b) .
Assay of endogenous 5-HT and 5-HIAA wing high pressure liquid chromatography
The high pressure liquid chromatography system employed in these studies was the LC-50 (Waters Associates, Milford, MA), which was equipped with a Whatman Guard Column (Whatman Inc., Clifton, NJ), a Waters uBondapack C-18 reverse-phase column (3.9 x 30 cm), and an LC-4A amperometric detector coupled to a TL-5 glassy carbon electrode (Bioanalytical Systems, West Lafayette, IN). Stainless steel tubing was used throughout. The mobile phase consisted of a sodium acetate buffer (0.1 M, pH 4.7) containing 6% methanol (Reinhard et al., 1980) . The flow rate was 2.0 ml/min and the column was operated at ambient temperature (20°C). The electrochemical detector was set on a current-tovoltage gain (sensitivity) of 5 nA/V, at a potential of 0.7 V, with the recorder set to give a full scale deflection with 1 V. All chemicals were of reagent grade. Water for the acetate buffer was deionized using a Millipore Milli-Q water purification system (Millipore Corp., Bedford, MA).
Tissues were homogenized in 10 vol of 0.1 M perchloric acid containing 0.23 mM ascorbic acid (prepared fresh daily), using a Teflon-glass homogenizer (clearance = 0.01 mm). Homogenates were centrifuged at 15,000 x g and the clear supernatants were injected directly into the injection post of the liquid chromatograph.
Results
Formation of protein-bound fH]5-HT in brain in vivo.
In order to determine whether 5-HT is physiologically bound to SBP in vivo, exogenous [3H]5-HT was used as a probe. The labeled amine was perfused into the cerebral ventricles so that it could be taken up by central serotonergic neurons in vivo. It is known that [3H]5-HT, taken up in this way, enters the physiologically releasable store of 5-HT (Chase et al., 1968; Jonakait et al., 1979) . Following perfusion, the labeled brain was homogenized so as to liberate the contents of synaptic vesicles. We have previously demonstrated the lability of serotonergic synaptic vesicles under these conditions (Tamir and Gershon, 1979) . The supernatant obtained from high speed centrifugation of the homogenate was passed through a molecular sieve column to separate bound from free [3H] 5-HT. The fraction containing the [3H]5-HT complexed to protein contained 4 + 1 (SE) x lo5 cpm (10 experiments; 20 determinations) and comprised 15 + 3% (SE) of the total radioactivity present in the supernatant fraction. This protein-bound material was then subjected to 10% SDS-PAGE to identify the SBP.
[3H]5-HT complex. We have previously shown that this complex is not completely dissociated by SDS under these conditions, and [3H]5-HT moves with SBP and serves as a marker for the protein in electropherograms (Tamir et al., 1980; Tamir, 1982) . The migration of the in vivo formed protein-bound [3H]5-HT on these gels was compared with that of [3H]5-HT complexed to partially purified SBP extracted from unlabeled whole brain. Two radioactive peaks were found (Fig. 1) . These corresponded to apparent molecular weights of 56,000 and 45,000. As noted previously (Tamir et al., 1980) , the [3H]5-HT complex with SBP extracted from brain also migrated with peaks corresponding to these same molecular weights; however, the 45-kd peak was dominant for the in vivo formed material (Fig. lA) , while the 56-kd peak was dominant when the complex was formed with extracted whole brain SBP (Fig. 1B) . Experiments were done to examine the molecular weights of the [3H]5-HT complex with SBP extracted from different regions of the CNS. The proportion of the 56-kd form to the 45-kd form was determined. The ratio, 56-k&45-kd, was 7.7 in the forebrain, 7.0 in the raphe region, and 1.5 in the spinal cord. The 45-kd form thus exists in fair quantity in at least one terminal field of serotonergic neurons, the spinal cord.
In these experiments it was found that significant quantities of protein-bound Since decreasing the time (to 15 min) or speed (to 15,000 x g) of centrifugation of the whole homogenate increased the percentage of protein-bound [3H]5-HT 5-fold, it is likely that either our homogenization procedure did not fully liberate the bound [3H]5-HT from vesicles, or the liberated material bound to membranes. SBP is hydrophobic and would be expected to so bind. We nevertheless used only the high speed supernatant for analysis to avoid contamination of our fractions with membranes.
Since homogenization liberates both free [3H]5-HT and SBP, it is possible that the complex between the two could form artifactually during or after homogenization. Conditions during homogenization were therefore made unfavorable for the formation of the complex in order to minimize this possibility. The homogenizing medium was kept at 4°C and was not fortified with Fe'+; nevertheless, HT has been shown to be exclusively into serotonergic axons (Gershon, 1982; Gershon and Sherman, 1982) . Following incubation, the LM-MP was homogenized and subjected to centrifugation, and the high speed super-800 I-400 natant was fractionated by molecular sieve chromatography and analyzed by 10% SDS-PAGE as was done for [3H]5-HT-perfused brain. Again, protein-bound [3H]5-HT was found (5 + 2 (SE) X lo5 cpm; 6 experiments; 12 determinations); moreover, as occurred with perfused brain, two peaks were resolved by SDS-PAGE corresponding to apparent molecular weights of 45,000 and 56,000 (Fig. 2) . Once more, the peak at 45 kd dominated ( Fig. 2A) . In the case of the gut, however, the 45-kd peak rons specifically (Chan-Palay, 1975; Calas et al., 1976;  This experiment was carried out five times. Parent et al., 1981; Descarries et al., 1982) ; however, radioautography was done here to determine where the label was located under the conditions of our experia control was done to estimate the extent of postmortem ments. In the brain, the most intense labeling was found formation of the [3H]5-HT. SBP complex. This control over periventricular regions and near the subarachnoid consisted of the addition of [3H]5-HT in a concentration space (Fig. 3) ; nevertheless, examination of the radioauslightly greater than that found in homogenates of per-tographs by darkfield microscopy revealed that, to some fused brain (3 x lo6 cpm) to nonperfused brain just prior degree, regions quite distant from the surfaces of the to homogenization. The control tissue was then treated brain contained radioactive material. Most of the labelin exactly the same way as was the experimental. Very ing, however, was of terminal fields, although some cell little protein-bound [3H]5-HT could be detected under bodies labeled also in the nuclei of the median raphe these conditions. The amount was 5 to 10% of that found (Fig. 3, C and D) . No cell bodies were labeled in regions in perfused brain and was too little to analyze by SDS-known not to contain serotonergic perikarya. These data Vol. 3, No. 10, Oct. 1983 The sample is derived, for example, more from axons than from cell bodies.
Penetration of [3H]5-HT into the myenteric plexus of dissected LM-MP preparations is not a problem. Both axons and cell bodies were found by EM radioautography to have been labeled in all parts of the plexus. The bulk of the labeling, however, was of axonal varicosities (Fig.  4) . These labeled varicosities consisted of a single set of structures characterized by the presence of small, electron-lucent synaptic vesicles and large dense cored vesicles. This set of varicosities could readily be distinguished from noradrenergic varicosities which were not labeled by [3H]5-HT and which contain small dense cored synaptic vesicles. The [3H]5-HT, following incubation of the ENS, thus was like the CNS, in that it predominantly labeled axonal varicosities and only to a lesser extent entered neuronal cell bodies. In preterminal axons, labeling by [3H]5-HT could be seen to be concentrated over regions rich in synaptic vesicles.
Formation of the $Hl5-HT. SBP complex in vivo: Dependence on endogenous 5-HT levels. Previously it has been noted that SBP extracted from brain must be dialyzed free of endogenous 5-HT in order to assay the binding protein with [3H]5-HT (Tamir et al., 1976; Jonakait et al., 1977) . This suggests that endogenous 5-HT is bound to SBP in vivo. If this is the case, then the capacity of SBP to bind exogenous [3H]5-HT in vivo may be limited by the amount of endogenous 5-HT already bound to the protein. In order to test this hypothesis;we sought to lower the endogenous 5-HT level, making the prediction that this procedure would increase the amount of protein-bound [3H]5-HT in brain following perfusion with [3H]5-HT. The brain 5-HT content was lowered by placing rats on a tryptophan-deficient diet to avoid the use of a drug, such as reserpine, that is known to affect SBP (Tamir et al., 1976; Jonakait et al., 1977) . In addition to protein binding of [3H]5-HT, the endogenous 5-HT and 5-HIAA concentration was also measured. Paired control (same chow with tryptophan) and experimental animals were perfused with [3H]5-HT and killed, and their brains were analyzed identically. The tryptophan-deficient animals lost weight and their brains became depleted of 5-HT and 5-HIAA (Fig. 5) . Protein-bound
[3H]5-HT, however, increased significantly in the tryptophan-deficient animals (p < 0.01 compared to matched controls; Fig. 5 ). The increase in protein-binding capacity for [3H]5-HT was highest after 5 days of dieting and did not increase further up to 11 days; however, weight loss was extreme by this time.
An attempt was also made to deplete 5-HT with the tryptophan hydroxylase inhibitor PCPA. This drug, however, inhibited the binding of [3H]5-HT to SBP, an effect that, unlike the action of PCPA treatment on tryptophan hydroxylase, could be reversed by dialysis. Nevertheless, these experiments were abandoned because the drug interacted with SBP so that no conclusions relevant to 5-HT levels and SBP binding could be drawn. (Tamir et al., 1982) . Addition of [3H]5-HT just prior to homogenization did not provide these results; therefore, the ["H]5-HT a SBP complex found in the in vivo experiments must have formed intracellularly, prior to homogenization, and thus was not an artifact of the method of analysis. These findings therefore support the hypothesis that 5-HT entering serotonergic neurons becomes complexed to SBP.
It is noteworthy that partially purified SBP provides two distinct species when analyzed by SDS-PAGE corresponding to apparent molecular weights of 45,000 and 56,000. It is possible that the 56-kd form is a precursor of the 45-kd material. Partially purified 56-kd SBP spontaneously yields 45-kd SBP when stored. This process is rapid at 37"C, slower at 4°C and occurs even at -20°C when the material is stored for over 4 weeks. Antibodies raised against the 56-kd SBP cross-react with the 45-kd protein (H. Tamir, personal observations). Whatever the significance of the two forms of SBP, the observation that [3H]5-HT is preferentially recovered bound to 45-kd SBP when the complex is formed in vivo, whereas the 56-kd material is dominant when the protein is extracted from whole brains, requires explanation. It seems likely that this apparent quantitative discrepancy is related to the nature of the procedure used to present the probe [3H]5-HT to SBP in vivo. Under the experimental conditions used, the 45-kd SBP has preferential access to [3H]5-HT. This phenomenon may, in turn, be related to the radioautographically demonstrated nonuniform distribution of [3H]5-HT in brain substance following ventricular perfusion or to the intracellular compartmentation of the two forms of SBP, or both. For example, the 45-kd form of SBP may represent the form of the molecule in the synaptic vesicles of serotonergic varicosities. Varicosities of terminal axons probably account for the bulk of the uptake of [3H]5-HT by brain and were found to be the major structure to be labeled by [3H]5-HT in the ENS. If vesicles contain the 45-kd but not the 56-kd material, therefore, the in vivo formed [3H]5-HT. SBP complex would mainly involve 45-kd SBP. This may not reflect the total SBP pool, however, which also includes cell bodies and preterminal axons. The 56-kd protein may predominate in these regions giving rise to the bulk of the unlabeled SBP that is extracted from homogenates of whole brain. The greater ratio of 56-kd to 45-kd SBP extracted from raphe regions in contrast to spinal cord is consistent with this interpretation, So too is the dominance of the 45-kd form of SBP extracted under any circumstances from the ENS. In the myenteric plexus there are relatively few serotonergic cell bodies and only short stretches of preterminal axons, but there is a dense concentration of varicose terminal axons. Alternatively, the two forms of SBP may be stored in different serotonergic neurons that differ in regional distribution. Some may have more of the larger molecule while others may contain more of the smaller. The nonuniform distribu- Further work is needed to distinguish between these possibilities. It will be particularly important to determine the relationship of the 56 kd SBP to the 45-kd material. If the 56-kd SBP is, in fact, the precursor of the 45-kd SBP in all serotonergic neurons and is converted to the smaller form of the molecule by post-translational modification, the case for a difference between the two in intraneuronal distribution would be strengthened. One additional possibility that must be considered is consistent with the data. It is known that there are multiple pools of 5-HT storage. Newly taken up and newly synthesized 5-HT are preferentially released (Macon et al., 1971; Gershon and Tamir, 1981b) . The labeling of the 45-kd form of SBP by [3H]5-HT taken up by serotonergic neurons in vivo suggests that binding to the 45-kd form may be involved in the storage of readily releasable 5-HT. Conceivably, the 56-kd SBP may be complexed with the more stably bound 5-HT. The EM radioautographic results obtained from axons of the ENS that were sectioned en passage show that [3H]5-HT preferentially labeled regions containing accumulations of synaptic vesicles (Fig. 4) . Portions of the same axons without vesicles were much less heavily labeled. The stimulated release of SBP, [3H]5-HT, and endogenous 5-HT from the ENS have all been found to be Ca2+-dependent (Jonakait et al., 1979; Gershon and Tamir, 1981b) . The location of [3H]5-HT in vesicles and the in vivo formation of a 45-kd SBP.
[3H]5-HT complex in enteric axons, therefore, are consistent with vesicular storage of releasable 5-HT together with 45kd SBP. Such storage would explain the simultaneous release of SBP and 5-HT (Jonakait et al., 1979) as an exocytotic event.
The increase in in vivo binding of [3H]5-HT to SBP that occurred when the concentration of brain 5-HT was lowered indicates that SBP must normally be nearly saturated with endogenous 5-HT. Curiously, the binding capacity of SBP for [3H]5-HT was increased proportionally more by serotonin depletion than can be accounted for by a linear correlation of binding capacity of SBP for [3H]5-HT. This might mean that tryptophan deficiency depletes 5-HT bound to SBP more than total 5-HT. Alternatively, tryptophan deficiency may deplete other proteins at a faster rate than SBP so that binding capacity, which is expressed per milligram of total protein, appears to increase greatly. Other explanations of the nonlinear relationship can be envisioned; however, the fact that the increase occurs at all supports the view, albeit indirectly, that endogenous 5-HT is bound to SBP and competes with the [3H]5-HT probe for available binding sites.
It is concluded that SBP functions as a binding or storage protein for 5-HT. The protein.5-HT complex is formed within serotonergic neurons in vivo. The role of the complex in the cellular biology of serotonergic neurons remains to be determined; however, reduction of osmotic pressure within synaptic vesicles is still a possibility.
